Can we formulate some new hypotheses about how to treat PCOS
Medical trials for specific uses have increased dosage to three or four times that, but this is under medical supervision and using different formats
Originally developed for type 2 diabetes, GLP-1 agonists have expanded into weight management as clinical evidence demonstrates their effects on satiety and metabolic function
FOXO4-DRI is a senolytic peptide a D-retro-inverso peptide engineered to selectively eliminate senescent "zombie" cells that accumulate with age and secrete inflammatory factors (the senescence-associated secretory phenotype, or SASP)
Am J Respir Crit Care Med 195(9):11811188 Baan EJ, de Roos EW, Engelkes M, de Ridder M, Pedersen L, Berencsi K et al (2022) Characterization of asthma by age of onset: A Multi-Database cohort study
Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS)